Skip to main navigation
Back
revance revance
  • Contact Revance
  • Login
Menu
  • Aesthetics
    Back Aesthetics
    Visit Site
    • Overview
    • RHA®
    • HintMD
    • Neuromodulator
    • Neuromodulator Uses
    • Clinical Highlights
  • Therapeutics
    Back Therapeutics
    • Overview
    • Cervical Dystonia
    • Upper Limb Spasticity
    • Plantar Fasciitis
    • Clinical Highlights
  • Investors
    Back Investors
    LATEST NEWS
    • Our Latest
    • December 22, 2020
    Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection All News
    • Investor Relations
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Analyst Coverage
    • Investor FAQ
    • Contact Us
  • Company
    Back Company
    OUR LATEST
    • Our Latest
    • December 22, 2020
    Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection Our Latest
    • Overview
    • About Revance
    • Leadership Team
    • Board of Directors
    • Partnerships
    • Investigator Sponsored Trials
    • Medical Education Grants
    • Sustainability
    • Contact Revance
  • News
  • Careers
    Back Careers
    • Overview
    • Career Opportunities
    • Culture
    • Benefits & Perks
  • facebook
  • instagram
  • twitter
  • linkedin
1222 Demonbreun St
Suite 2000
Nashville, TN 37203
+1 (510) 742-3400
  • Contact Revance
  • Login

© Copyright 2021

All Rights Reserved

Terms of Use

Privacy Policy

Breadcrumb

  • Home
  • Investors
  • Press releases

Press Releases

Press Releases

May 8, 2019
Revance Reports First Quarter 2019 Financial Results and Provides Corporate Update
April 24, 2019
Revance to Release First Quarter 2019 Financial Results on Wednesday, May 8, 2019
April 9, 2019
Revance Appoints Former Allergan Marketing Veteran Taryn Conway as Vice President of Marketing
April 8, 2019
SAKURA 3 Trial Results Presented on Podium at World’s Largest Medical Aesthetic Conference
April 2, 2019
Revance to Participate in the Needham Healthcare Conference
March 5, 2019
Revance to Participate in Upcoming Investor Conferences
February 26, 2019
Revance Releases Fourth Quarter and Full Year 2018 Results
February 12, 2019
Revance to Release Fourth Quarter and Full Year 2018 Financial Results on Tuesday, February 26, 2019
January 22, 2019
Revance Announces Closing of Public Offering of Common Stock
January 17, 2019
Revance Announces Pricing of Public Offering of Common Stock

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Next page next ›
  • Last page last »
Displaying 81 - 90 of 245

Investor Relations

  • Investor Relations
  • Press Releases
  • Events & Presentations
    • Events
    • Presentations and Corporate Materials
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Investor FAQs
  • Contact Us
image description

Revance - Shareholder Tools

  • Print Page
  • Printed Materials
  • Email Alerts
  • Download Library
  • RSS News Feeds
  • Share
  • Search

Keep up with Revance

revance
1222 Demonbreun St
Suite 2000
Nashville, TN 37203
+1 (510) 742-3400
  • facebook
  • instagram
  • twitter
  • linkedin

Aesthetics

  • Overview
  • RHA®
  • HintMD
  • Neuromodulator
  • Neuromodulator Uses
  • Clinical Highlights

Therapeutics

  • Overview
  • Cervical Dystonia
  • Upper Limb Spasticity
  • Plantar Fasciitis
  • Clinical Highlights

Investors

  • Investor Relations
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Investor FAQ
  • Contact Us

Company

  • Overview
  • About Revance
  • Leadership Team
  • Board of Directors
  • Partnerships
  • Investigator Sponsored Trials
  • Medical Education Grants
  • Sustainability
  • Contact Revance

News

  • All News
  • In the News
  • Our Latest

Careers

  • Overview
  • Career Opportunities
  • Culture
  • Benefits & Perks
  • © Copyright 2021
  • All Rights Reserved
  • Terms of Use
  • Privacy Policy
  • Corporate Social Media Community Guidelines
Back to top
  • Facebook
  • LinkedIn